Ryvu Therapeutics Presents Clinical and Translational Data of RVU120 and SEL24…
RVU120 Demonstrates Single-Agent Activity with a Complete Response, 4 Blast Reductions, and 4 Erythroid and/or Platelet responses in Patients with Relapsed/Refractory Acute Myeloid Leukemia…